JP2017505338A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505338A5
JP2017505338A5 JP2016563903A JP2016563903A JP2017505338A5 JP 2017505338 A5 JP2017505338 A5 JP 2017505338A5 JP 2016563903 A JP2016563903 A JP 2016563903A JP 2016563903 A JP2016563903 A JP 2016563903A JP 2017505338 A5 JP2017505338 A5 JP 2017505338A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
item
position corresponding
composition according
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016563903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505338A (ja
JP6944780B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/011202 external-priority patent/WO2015106269A2/en
Publication of JP2017505338A publication Critical patent/JP2017505338A/ja
Publication of JP2017505338A5 publication Critical patent/JP2017505338A5/ja
Application granted granted Critical
Publication of JP6944780B2 publication Critical patent/JP6944780B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016563903A 2014-01-13 2015-01-13 速効型インスリン製剤及び医薬送達システム Active JP6944780B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461926944P 2014-01-13 2014-01-13
US201461926946P 2014-01-13 2014-01-13
US61/926,946 2014-01-13
US61/926,944 2014-01-13
PCT/US2015/011202 WO2015106269A2 (en) 2014-01-13 2015-01-13 Rapid action insulin formulations and pharmaceutical delivery systems

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2019014241A Division JP2019081773A (ja) 2014-01-13 2019-01-30 速効型インスリン製剤及び医薬送達システム
JP2020136982A Division JP2020189875A (ja) 2014-01-13 2020-08-14 速効型インスリン製剤及び医薬送達システム

Publications (3)

Publication Number Publication Date
JP2017505338A JP2017505338A (ja) 2017-02-16
JP2017505338A5 true JP2017505338A5 (cg-RX-API-DMAC10.html) 2018-02-08
JP6944780B2 JP6944780B2 (ja) 2021-10-06

Family

ID=53524484

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016563903A Active JP6944780B2 (ja) 2014-01-13 2015-01-13 速効型インスリン製剤及び医薬送達システム
JP2019014241A Pending JP2019081773A (ja) 2014-01-13 2019-01-30 速効型インスリン製剤及び医薬送達システム
JP2020136982A Pending JP2020189875A (ja) 2014-01-13 2020-08-14 速効型インスリン製剤及び医薬送達システム

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019014241A Pending JP2019081773A (ja) 2014-01-13 2019-01-30 速効型インスリン製剤及び医薬送達システム
JP2020136982A Pending JP2020189875A (ja) 2014-01-13 2020-08-14 速効型インスリン製剤及び医薬送達システム

Country Status (10)

Country Link
US (4) US9901622B2 (cg-RX-API-DMAC10.html)
EP (1) EP3094343A4 (cg-RX-API-DMAC10.html)
JP (3) JP6944780B2 (cg-RX-API-DMAC10.html)
KR (1) KR102351111B1 (cg-RX-API-DMAC10.html)
CN (1) CN106102763A (cg-RX-API-DMAC10.html)
AU (1) AU2015204491B2 (cg-RX-API-DMAC10.html)
BR (1) BR112016016290A2 (cg-RX-API-DMAC10.html)
CA (1) CA2936563A1 (cg-RX-API-DMAC10.html)
IL (1) IL246706B (cg-RX-API-DMAC10.html)
WO (1) WO2015106269A2 (cg-RX-API-DMAC10.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005023458D1 (de) 2005-09-12 2010-10-21 Unomedical As Einfürungssystem für ein Infusionsset mit einem ersten und zweiten Federeinheit
KR20130018783A (ko) 2010-03-30 2013-02-25 우노메디컬 에이/에스 의료기구
US10194938B2 (en) 2011-03-14 2019-02-05 UnoMedical, AS Inserter system with transport protection
WO2013050277A1 (en) 2011-10-05 2013-04-11 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
EP2919804B1 (fr) 2012-11-13 2018-01-31 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
CA2936563A1 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
AR102869A1 (es) 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
WO2016105545A2 (en) * 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
US10780222B2 (en) 2015-06-03 2020-09-22 Pacific Diabetes Technologies Inc Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
US11357912B2 (en) 2016-01-19 2022-06-14 Unomedical A/S Cannula and infusion devices
AU2017361524B2 (en) 2016-11-21 2022-06-02 Case Western Reserve University Rapid-acting insulin analogues of enhanced stability
US10709834B2 (en) * 2016-12-21 2020-07-14 Medtronic Minimed, Inc. Medication fluid infusion set component with integrated physiological analyte sensor, and corresponding fluid infusion device
UY37629A (es) 2017-03-07 2018-10-31 Univ Case Western Reserve Análogos de insulina de cadena simple estabilizados por un cuarto puente disulfuro
GB201707189D0 (en) * 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707187D0 (en) * 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
CA3065308C (en) 2017-06-01 2022-05-17 Eli Lilly And Company Rapid-acting insulin compositions
WO2019050749A1 (en) 2017-09-08 2019-03-14 Eli Lilly And Company PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST ONE AGENT SELECTED AMONG MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYLIC ACID AND PARACETAMOL
CN108489941B (zh) * 2018-01-31 2021-07-27 吉林大学 溴酚蓝在作为检测牛胰岛素淀粉样纤维探针和作为牛胰岛素淀粉样纤维抑制剂方面的应用
EP3773474B1 (en) * 2018-04-04 2026-01-07 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
BR112021005366A2 (pt) * 2018-09-21 2021-06-29 Case Western Reserve University análogo de insulina de cadeia simples, uso deste e método para reduzir o açúcar no sangue de um paciente
CA3139946A1 (en) * 2019-05-17 2020-11-26 Case Western Reserve University Variant single-chain insulin analogues
EP3972672A4 (en) 2019-05-20 2023-06-21 Unomedical A/S Rotatable infusion device and methods thereof
EP4051337A4 (en) * 2019-10-30 2023-11-01 Thermalin Inc. DRUG RELEASE SYSTEMS, DEVICES AND METHODS
US12610742B2 (en) 2019-11-25 2026-04-21 Aita Bio Inc. Micropump and method of fabricating the same
NL2025679B1 (en) * 2020-05-26 2021-12-13 Johanna Daams Brechtje Electrical stimulation for preventing or treating nitric oxide deficiency related conditions
CN122376921A (zh) 2020-08-23 2026-07-14 太平洋糖尿病科技公司 用于递送胰岛素或胰岛素类似物制剂和测量皮下葡萄糖浓度的装置
US20220386905A1 (en) * 2021-03-02 2022-12-08 Pacific Diabetes Technologies Inc Signal processing algorithm for improving accuracy of a continuous glucose sensor and a combined continuous glucose sensor and insulin delivery cannula
KR102678960B1 (ko) * 2021-08-26 2024-06-27 주식회사 에이피알 바디 관리기
US20240149021A1 (en) * 2022-11-04 2024-05-09 Becton, Dickinson And Company Intravenous Catheter Securement Sleeve
US20240216649A1 (en) * 2023-01-03 2024-07-04 Becton, Dickinson And Company Management of Catheters and Accessories During Intravascular Catheter Maintenance
US20250242110A1 (en) * 2024-01-26 2025-07-31 Medtronic Minimed, Inc. Fluid delivery filters
WO2025245624A1 (en) * 2024-05-28 2025-12-04 Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.E.C. New insulin formulations for use in insulin pumps

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134691D0 (da) * 1991-07-12 1991-07-12 Novo Nordisk As Apparat
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
AR012894A1 (es) * 1997-06-13 2000-11-22 Lilly Co Eli Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
WO2003053460A1 (en) * 2001-12-19 2003-07-03 Eli Lilly And Company Crystalline compositions for controlling blood glucose
US20080090753A1 (en) * 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US8343914B2 (en) 2006-01-06 2013-01-01 Case Western Reserve University Fibrillation resistant proteins
WO2007121256A2 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
EP2074140B8 (en) 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
US9220837B2 (en) * 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
AU2008233220B2 (en) * 2007-03-30 2013-01-10 Instrumentation Laboratory Company Adaptor for sample vial
WO2009129250A2 (en) 2008-04-14 2009-10-22 Case Western Reserve University Meal-time insulin analogues of enhanced stability
AU2009240636A1 (en) 2008-04-22 2009-10-29 Case Western Reserve University Isoform-specific insulin analogues
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
KR20120129875A (ko) 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
EP2318432B1 (en) * 2008-07-31 2015-09-02 Case Western Reserve University Halogen-stabilized insulin
JP5789515B2 (ja) * 2008-12-19 2015-10-07 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation インスリン類似体
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US20120184488A1 (en) 2009-09-01 2012-07-19 Case Western Reserve University Insulin analogues of enhanced receptor-binding specificity
US8399407B2 (en) 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
RU2012123642A (ru) * 2009-12-11 2014-01-20 Кейз Вестерн Ризев Юнивесити Аналоги инсулина, содержащие хлорированные аминокислоты
BR112012020481A2 (pt) 2010-02-22 2017-01-10 Univ Case Western Reserve método para tratar um paciente, o método compreendendo administrar uma formulação farmacêutica contendo uma quantidade fisiologicamente efetiva de um análogo de insulina ou um sal fisiologicamente.
WO2013010048A2 (en) 2011-07-13 2013-01-17 Case Western Reserve University Non-standard insulin analogues
EP2771026A4 (en) 2011-10-27 2015-08-05 Univ Case Western Reserve ULTRA-CONCENTRATED AND FAST-ACTING INSULIN ANALOG FORMULATIONS
JP6117811B2 (ja) * 2011-10-31 2017-04-19 ゼリス ファーマシューティカルズ インコーポレイテッド 糖尿病を処置するための製剤
CN104168911A (zh) * 2012-01-20 2014-11-26 卡斯西部储备大学 谷氨酸-稳定的胰岛素类似物
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
MX2015005662A (es) 2012-11-05 2015-08-20 Univ Case Western Reserve Analogos de insulina de una sola cadena de larga accion.
EP2948166B1 (en) 2013-01-22 2020-12-09 Case Western Reserve University N-terminal truncated insulin analogues
JP2016516728A (ja) 2013-03-15 2016-06-09 ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University 第2部位インスリン類似体
CA2936563A1 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
AU2015328222B9 (en) 2014-10-06 2020-12-24 Case Western Reserve University Biphasic single-chain insulin analogues
JP2017537065A (ja) 2014-10-20 2017-12-14 ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University 生物学的作用強度の高いハロゲン化インスリン類似体
WO2016105545A2 (en) 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
JP2018505874A (ja) 2015-01-20 2018-03-01 ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University 選択的シグナリング特性及びより低い分裂促進性を有するインスリンアナログ

Similar Documents

Publication Publication Date Title
JP6944780B2 (ja) 速効型インスリン製剤及び医薬送達システム
CN102245624B (zh) 基于酰胺的胰岛素前药
US11174303B2 (en) Single-chain insulin analogues stabilized by a fourth disulfide bridge
JP4959005B2 (ja) 毎日の注射頻度より少ないインスリン注射での真性糖尿病の治療
JP2014159431A (ja) 血糖降下剤の投与方法
JP2016512255A5 (cg-RX-API-DMAC10.html)
JP2017105790A5 (cg-RX-API-DMAC10.html)
JP2011524418A5 (cg-RX-API-DMAC10.html)
RU2012153753A (ru) Пептиды глюкагонового суперсемейства, обладающие активностью в отношении сопряженных с g-белком рецепторов
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
JP2015508285A (ja) 糖尿病治療のためのctp系インスリンアナローグ
EP3706774A1 (en) Glp-2 analogs and peptibodies for administration before during, or after surgery
RU2012136530A (ru) Новые соединения, влияющие на пищевое поведение
WO2020236762A3 (en) Variant single-chain insulin analogues
EP4144362A1 (en) Compositions comprising short-acting hormones for treating or preventing obesity and pumps comprising said composition
RU2006103280A (ru) Производные инсулина
CN103119057A (zh) 基于酰胺的胰岛素前药
JPWO2003064462A1 (ja) Peg結合pth又はpeg結合pth誘導体
WO2005016953A2 (en) Antagonistic analogs of gh-rh (2003)
JP2024531773A (ja) アルギナーゼ-インスリン融合タンパク質
JP2019533004A (ja) hGH融合タンパク質を含有する、成長ホルモン欠乏症を治療するための医薬組成物
JP6049625B2 (ja) 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
JP2017537065A (ja) 生物学的作用強度の高いハロゲン化インスリン類似体
JP3638316B2 (ja) イオントフォレシス用マトリックス
Kesavadev et al. Newer insulins on the horizon